French biotech Cellectis has devised a form of CAR-T that contains its therapeutic effects with a safeguard in a single molecule.

Scientists at American University have discovered a potential method for treating obesity.

Biotech developments over the past week include using circulating RNA to predict preemie births and a new way to free up stiffened heart muscle.

The discovery of inherited genetic variants that raise the risk of prostate cancer could improve screening, treatment and prevention of the disease.

Transplanting pancreatic islets, along with a hydrogel that "trains" immune cells to accept them, could translate to a cure for Type 1 diabetes.

The genetic map could highlight potential therapeutic targets, help repurpose drugs for new indications and identify side effects.

Two new studies suggest that blocking the cytokine IL-1 with a rheumatoid arthritis drug could treat neurological side effects of CAR-T treatments.

A modified form of poliovirus seems to shrink breast tumors by latching onto a protein that's heavily expressed on the surface of some cancer cells.

UC San Francisco scientists used a process called synNotch signaling to prompt individual cells to form tissue structures.

Scientists have developed a small molecule that can selectively target RNA and could pave the way for a pill that can treat genetic diseases.